FLVCR1-DT: A Potential Drug Target Or Biomarker (G642946)

Target Name: FLVCR1-DT

NCBI ID: G642946

FLVCR1-DT

Other Name(s): FLVCR1 divergent transcript, transcript variant 1 | FLVCR1-AS1 | LQK1 | FLVCR1 divergent transcript | NCRNA00292

FLVCR1-DT: A Potential Drug Target Or Biomarker

FLVCR1-DT, also known as FLVCR1 gene, is a protein that is expressed in various tissues of the body, including the brain, heart, and lungs. It is a member of the CR1 family of transmembrane proteins, which are characterized by the presence of a extracellular domain and a transmembrane region. The FLVCR1 gene has been implicated in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the unique features of FLVCR1 is its ability to undergo alternative splicing, which means that it can produce multiple proteins with different lengths and sequences. This gene has been shown to produce a range of spliced variants, including FLVCR1-DT, which has been identified as a potential drug target or biomarker.

The FLVCR1-DT protein is composed of a unique transmembrane region that is characterized by the presence of a unique protein domain known as the N-terminal transmembrane domain. This domain is composed of a series of conserved amino acids that are involved in the formation of a transmembrane protein that is involved in various signaling pathways.

One of the key functions of the FLVCR1-DT protein is its role in the regulation of cell signaling pathways. It is involved in the signaling pathways that are responsible for cell growth, differentiation, and survival. This protein has been shown to be involved in the regulation of several signaling pathways, including the TGF-β pathway, the PI3K/Akt pathway, and the NF-kappa-B pathway.

FLVCR1-DT has also been shown to be involved in the regulation of cellular transport processes. This protein is involved in the transport of various molecules across the membrane of the cell, including proteins involved in intracellular signaling pathways, as well as proteins involved in the production and degradation of cellular waste products.

In addition to its role in cellular signaling and transport processes, FLVCR1-DT has also been shown to be involved in the regulation of cellular inflammation. This protein has been shown to be involved in the regulation of the immune response, and is involved in the production of antibodies that are involved in the regulation of cellular immune responses.

The potential drug target or biomarker properties of FLVCR1-DT are due to its unique structure and its involvement in several important cellular processes. It is possible that this protein could be targeted by small molecules or antibodies that are designed to modulate its function and have the potential to treat a range of diseases. Further research is needed to fully understand the role of FLVCR1-DT in the development and progression of various diseases.

Protein Name: FLVCR1 Divergent Transcript

The "FLVCR1-DT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FLVCR1-DT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets